Gregory Demopulos
Chief Executive Officer at OMEROS CORPORATION
Net worth: 6 M $ as of 29/04/2024
Gregory Demopulos active positions
| Companies | Position | Start | End |
|---|---|---|---|
| OMEROS CORPORATION | Chief Executive Officer | 15/06/1994 | - |
| Chairman | 15/06/1994 | - | |
| Founder | 04/10/2009 | - | |
| President | 15/06/1994 | - | |
| Chief Tech/Sci/R&D Officer | 15/06/1994 | 02/05/2010 | |
| Director of Finance/CFO | 02/05/2010 | 16/10/2013 | |
| Treasurer | 02/05/2010 | 18/06/2014 | |
Tessera, Inc.
 Tessera, Inc. SemiconductorsElectronic Technology Tessera, Inc. provides packaging solutions for the semiconductor industry. The company was founded on December 16, 1992 and is headquartered in San Jose, CA. | Director/Board Member | - | - |
Onconome, Inc.
 Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | Director/Board Member | - | - |
| Smead Funds Trust | Director/Board Member | - | - |
| Northwest NeuroNeighborhood | Director/Board Member | - | - |
Career history of Gregory Demopulos
Training of Gregory Demopulos
| Stanford University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 7 |
| Israel | 2 |
Operational
| Director/Board Member | 4 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| OMEROS CORPORATION | Health Technology |
| Private companies | 4 |
|---|---|
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | Health Technology |
| Smead Funds Trust | Miscellaneous |
Tessera, Inc.
Tessera, Inc. SemiconductorsElectronic Technology Tessera, Inc. provides packaging solutions for the semiconductor industry. The company was founded on December 16, 1992 and is headquartered in San Jose, CA. | Electronic Technology |
| Northwest NeuroNeighborhood |
- Stock Market
- Insiders
- Gregory Demopulos
- Experience
